Saul Centers Inc
Change company Symbol lookup
Select an option...
BFS Saul Centers Inc
ABB Abb Ltd
BURL Burlington Stores Inc
TNEN True North Energy Corp
H Hyatt Hotels Corp
ACEL Accel Entertainment Inc
USLM United States Lime & Minerals Inc
BWEN Broadwind Inc
EQIX Equinix Inc
TXMD TherapeuticsMD Inc
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Blend
Company profile

Saul Centers, Inc. is a real estate investment trust (REIT). The Company, which conducts all its activities through its subsidiaries, the Operating Partnership and Subsidiary Partnerships, engaged in the ownership, operation, management, leasing, acquisition, renovation, expansion, development and financing of community and neighborhood shopping centers and mixed-used properties. The Company operates through two business segments: Shopping Centers and Mixed-Use Properties. The Company operates and manages a real estate portfolio of approximately 61 properties which includes 50 community and neighborhood shopping centers and seven mixed-use properties with approximately 9.8 million square feet of leasable area, and approximately four land and development properties. The Company’s properties are in the metropolitan Washington, DC/Baltimore metropolitan area.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$49.09
Day's Change
1.00 (2.08%)
Bid
--
Ask
--
B/A Size
--
Day's High
49.37
Day's Low
48.50
Volume
(Heavy Day)
Volume:
37,795

10-day average volume:
29,035
37,795

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Karuna Therapeutics, Inc. with Losses to Contact the Firm

2:30 pm ET June 18, 2022 (Accesswire) Print

LOS ANGELES, CA / ACCESSWIRE / June 18, 2022 /The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofKaruna Therapeutics, Inc. ("Karuna" or "the Company") (NASDAQ:KRTX) for violations of the securities laws.

The Schall Law Firm, Friday, June 17, 2022, Press release picture

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

SOURCE: The Schall Law Firm





View source version on accesswire.com:

https://www.accesswire.com/705689/INVESTIGATION-REMINDER-The-Schall-Law-Firm-Encourages-Investors-in-Karuna-Therapeutics-Inc-with-Losses-to-Contact-the-Firm



comtex tracking

COMTEX_408893057/2457/2022-06-18T14:30:58

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.